Streetbeat News

Stock Prices

SOND

Sonder shares have resumed trading, which could indicate a resolution of previous issues that halted trading. Investors should monitor the situation closely for further developments.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:41 pm

ALZN

Alzamend Neuro Inc. (NASDAQ:ALZN) stock surged after announcing a partnership with Massachusetts General Hospital for a Phase 2 study of AL001 for PTSD treatment. The study aims to assess lithium levels in the brain compared to marketed lithium salts. Alzamend hopes to meet FDA safety standards through the Section 505(b)(2) pathway.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:41 pm

XPEV

XPeng Inc (NYSE:XPEV) is facing bearish signals ahead of its Mona M03 launch on Aug. 27, following its Q2 earnings report on Aug. 20. The stock is down over 50% YTD and is trading below key moving averages, indicating a downward trend. Analysts see a potential 26.23% upside with a price target of $9.

Portfolio Pulse from Surbhi Jain

August 19, 2024 | 1:36 pm

SOND

Sonder shares experienced a significant surge, triggering a circuit breaker as the stock rose by 71%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:36 pm

TLS

Telos Corporation, an official TSA PreCheck enrollment provider, has expanded its services to eight new locations across the U.S., increasing its total to 91 centers. This expansion is part of Telos' ongoing efforts to enhance convenience for consumers by offering more enrollment centers and extended hours.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:30 pm

HIMS

LLY

NVO

Hims & Hers Health Inc (NYSE:HIMS) has seen its stock soar over 120% since August 2023 due to high demand for compounded weight-loss drugs amid supply shortages. This surge surpasses gains by Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). Hims capitalized on the scarcity of GLP-1 drugs by offering affordable alternatives, but faces legal challenges and potential stock vulnerability once shortages resolve.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:24 pm

TOVX

Theriva Biologics (NASDAQ:TOVX) shares dropped 15% to $0.17 after announcing a 1-for-25 reverse stock split, effective August 26, to meet NYSE American's per-share price requirements. The split will reduce outstanding shares from 25,131,230 to 1,005,249.

Portfolio Pulse from Henry Khederian

August 19, 2024 | 1:22 pm

TOVX

Theriva Biologics shares declined following the announcement of a 1-for-25 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:21 pm

DIS

FOXA

FOXB

FUBO

WBD

FuboTV Inc (NYSE:FUBO) shares surged 15.7% after obtaining a preliminary injunction against a joint venture by Disney, Fox, and Warner Bros Discovery. The injunction halts the JV, which Fubo argued would monopolize sports streaming. Fubo plans to continue its antitrust lawsuit against these companies.

Portfolio Pulse from Henry Khederian

August 19, 2024 | 1:16 pm

AMD

ASTS

CLOV

INTC

LOT

MADE

NVDA

RKLB

WAY

ZIM

The article lists the top 10 trending stocks on WallStreetBets as of August 19, 2024, based on data from Swaggy Stocks. The stocks mentioned are AMD, ASTS, CLOV, INTC, LOT, MADE, NVDA, RKLB, WAY, and ZIM.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:14 pm